Kruse, C A <br/><br/>
Purified herpes simplex thymidine kinase Retrovector particles. I. In vitro characterization, in situ transduction efficiency, and histopathological analyses of gene therapy-treated brain tumors.  [electronic resource] 

 -  Cancer gene therapy   
 - 118-28 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0929-1903 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antimetabolites--pharmacology<br/>Brain Neoplasms--drug therapy<br/>CD4-Positive T-Lymphocytes<br/>CD8-Positive T-Lymphocytes<br/>Cell Division--genetics<br/>Ganciclovir--pharmacology<br/>Genetic Therapy--methods<br/>Genetic Vectors--chemistry<br/>Gentamicins--pharmacology<br/>Hexadimethrine Bromide--chemistry<br/>Immunohistochemistry<br/>Male<br/>Neoplasms, Experimental--drug therapy<br/>Rats<br/>Rats, Inbred Strains<br/>Retroviridae--genetics<br/>Simplexvirus--enzymology<br/>Thymidine Kinase--drug effects<br/>Transduction, Genetic<br/>beta-Galactosidase--genetics